BURLINGAME, Calif.--(BUSINESS WIRE)--Pyxis One, a California-based tech startup that aims to revolutionize marketing and consumer intelligence by providing an all-in-one, codeless AI platform, closed ...

Blackmagic's latest test firmware build brings phase-detection autofocus to the PYXIS 6K, with linear focus support, resizable focus box, and a bug fix for headphone startup hang.

Pyxis Oncology is aiming to close out a transformative 2021 with an IPO. Having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a megaround to develop them, Pyxis is now ...

Pyxis Oncology needs to pave a longer cash runway. To do so, the Pfizer-partnered antibody-drug conjugate (ADC) biotech is cutting 40% of staff, slimming its programs and looking to monetize royalty ...

The first reviews of the Blackmagic PYXIS 6K are starting to circulate, with Sean Viljoen’s video of filming with it at the Imire Game Reserve in Zimbabwe showcasing some impressive capabilities. Sean ...

Pyxis Tankers is an obscure shipping company with a $46.17 million market cap and owns three product tankers and two bulk carriers. The company has a healthy balance sheet with $31 million cash and ...

Pyxis One, now Pixis, closed on $100 million in Series C funding to continue developing what it touts as “the world’s only contextual codeless AI infrastructure for complete marketing optimization.” ...

Pyxis Tankers Inc. (Nasdaq Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for the three months ...

Antibody drug conjugates, or ADCs, are picking up momentum. Of the 11 drugs in this class that have been approved by the FDA, six have reached the market in the last two years. Meanwhile, new ADC ...

Pyxis Oncology (PYXS) is a good speculative biotech play to look into. The reason why I state that is because even though it deploys antibody drug-conjugate [ADC] technology, it is taking a holistic ...

Pyxis Oncology, Inc. is reallocating its resources to focus on the development of its leading asset, PYX-201, a pioneering antibody-drug conjugate (ADC) showing promising efficacy in treating head and ...

Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international diversified shipping company with a focus on the seaborne transportation of refined petroleum products and dry bulk commodities, today ...